Insider · CIK 0002081380
Rui Fang
Files at YB (Yuanbao Inc.). First filing -, latest -.
In brief
Rui Fang files SEC Form 4 as CEO, director and 10% owner at YB (Yuanbao Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rui Fang has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | YB Yuanbao Inc. | FTax withholding American Depositary Sharesderivative | -14,737 | $12.31 | $181k | 115,263 | 19 d ago |
| Sep 24, 2026 | YB Yuanbao Inc. | MOption exercise Options (Right to Buy)derivative | -4,998 | $0.00 | $0 | 870,002 | 19 d ago |
| Sep 24, 2026 | YB Yuanbao Inc. | MOption exercise American Depositary Sharesderivative | +833 | - | - | 116,096 | 19 d ago |
| Sep 24, 2026 | YB Yuanbao Inc. | SOpen-market sale American Depositary Sharesderivative | -440 | $12.16 | $5,350 | 115,656 | 19 d ago |
| Sep 24, 2026 | YB Yuanbao Inc. | MOption exercise Options (Right to Buy)derivative | -5,700 | $0.00 | $0 | 952,300 | 19 d ago |
| Sep 24, 2026 | YB Yuanbao Inc. | MOption exercise American Depositary Sharesderivative | +950 | - | - | 116,606 | 19 d ago |
| Sep 24, 2026 | YB Yuanbao Inc. | SOpen-market sale American Depositary Sharesderivative | -573 | $12.15 | $6,962 | 116,033 | 19 d ago |
| Sep 24, 2026 | YB Yuanbao Inc. | MOption exercise Options (Right to Buy)derivative | -4,998 | $0.00 | $0 | 795,002 | 19 d ago |
| Sep 24, 2026 | YB Yuanbao Inc. | MOption exercise American Depositary Sharesderivative | +833 | - | - | 116,866 | 19 d ago |
| Sep 24, 2026 | YB Yuanbao Inc. | SOpen-market sale American Depositary Sharesderivative | -258 | $12.15 | $3,135 | 116,608 | 19 d ago |
| Sep 24, 2026 | YB Yuanbao Inc. | SOpen-market sale American Depositary Sharesderivative | -173 | $12.11 | $2,095 | 116,435 | 19 d ago |
| Sep 16, 2026 | YB Yuanbao Inc. | AGrant or award Options (Right to Buy)derivative | +480,000 | $0.00 | $0 | 480,000 | 26 d ago |
| Sep 16, 2026 | YB Yuanbao Inc. | AGrant or award Restricted Share Unitsderivative | +600,000 | $0.00 | $0 | 1,200,000 | 26 d ago |
| Sep 16, 2026 | YB Yuanbao Inc. | MOption exercise Restricted Share Unitsderivative | -180,000 | $0.00 | $0 | 1,020,000 | 26 d ago |
| Sep 16, 2026 | YB Yuanbao Inc. | MOption exercise American Depositary Sharesderivative | +30,000 | $0.00 | $0 | 130,000 | 26 d ago |
| Sep 16, 2026 | YB Yuanbao Inc. | FTax withholding American Depositary Sharesderivative | -14,850 | $12.44 | $185k | 115,150 | 26 d ago |
| May 26, 2026 | YB Yuanbao Inc. | MOption exercise Options (Right to Buy)derivative | -300,000 | $0.00 | $0 | 800,000 | May 28, 2026 |
| May 26, 2026 | YB Yuanbao Inc. | MOption exercise American Depositary Sharesderivative | +50,000 | - | - | 100,000 | May 28, 2026 |
| May 8, 2026 | YB Yuanbao Inc. | MOption exercise Options (Right to Buy)derivative | -300,000 | $0.00 | $0 | 1,100,000 | May 11, 2026 |
| May 8, 2026 | YB Yuanbao Inc. | MOption exercise American Depositary Sharesderivative | +50,000 | - | - | 50,000 | May 11, 2026 |
Questions about Rui Fang
Answered from the filings on this page, as of the latest one.
Is Rui Fang buying or selling?
Rui Fang has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rui Fang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rui Fang has 0.
Where does Rui Fang file Form 4?
Rui Fang has filed Form 4 at YB (Yuanbao Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.